Pharmapacks, a leading online pharmacy retailer, has secured a $250 million dollar investment from the Carlyle Group, bringing its overall valuation to $1.1 billion. This comes as the demand for online goods continues to grow amid the coronavirus pandemic. Andrew Vagenas, CEO of Pharmapacks, joined Wake Up With Cheddar for more.